About Gynoveda
Gynoveda is a company based in Mumbai (India) founded in 2019 by Aarati Patil, Vishal Gupta, and Rachana Gupta. Gynoveda has raised $10.95 million across 3 funding rounds from investors including Ex Libris Group, Wipro and India Alternatives. The company has 95 employees as of October 09, 2025. Gynoveda offers products and services including Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and White Discharge Tablets. Gynoveda operates in a competitive market with competitors including Sanfe, MildCares, Auntfloh, Aurelle Health and VWash, among others.
- Headquarter Mumbai, India
- Employees 95 as on 09 Oct, 2025
- Founders Aarati Patil, Vishal Gupta, Rachana Gupta
- Stage Minicorn
-
Sectors
HealthcareConsumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gynoveda Femtech Private Limited
- Date of Incorporation 05 Jul, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$7.85 M (USD)17.09as on Mar 31, 2024
-
Net Profit
-$365.09 K (USD)71.32as on Mar 31, 2024
-
EBITDA
-$756.26 K (USD)41.7as on Mar 31, 2024
-
Total Equity Funding
$10.95 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Mar 03, 2023
-
Investors
Ex Libris Group
& 9 more
-
Employee Count
95
as on Oct 09, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gynoveda
Gynoveda offers a comprehensive portfolio of products and services, including Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and White Discharge Tablets.
Boost fertility and improve egg quality naturally
Reverse PCOS and regulate monthly cycles effectively
Improve menstrual flow and ensure timely cycles
Regulate cycles and control heavy menstrual flow
Treat itching and discharge for intimate health
Manage weight and hot flashes during menopause
Reduce damage from smoking and environmental pollution
Restore blood lost during menstrual cycles
Prevent knee pain and support bone health
People of Gynoveda
Unlock access to complete
Funding Insights of Gynoveda
Gynoveda has successfully raised a total of $10.95M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gynoveda
Gynoveda has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ex Libris Group, Wipro and India Alternatives.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Venture debt funding and structured finance for innovative startups in India.
|
Locked | Locked | Locked | |
|
RPG Ventures is focused on incubating and investing in new businesses.
|
Locked | Locked | Locked |
Investor details for Gynoveda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gynoveda
Investment portfolio details for Gynoveda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gynoveda
Detailed financials for Gynoveda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gynoveda Comparisons
Peer comparison for Gynoveda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gynoveda
Gynoveda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanfe, MildCares, Auntfloh, Aurelle Health and VWash, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personal hygiene and body care products for women are provided.
|
|
| Locked | Locked | Locked |
An online internet-first brand offering menstrual hygiene products
|
|
| Locked | Locked | Locked |
Developer PMS relief supplements
|
|
| Locked | Locked | Locked |
Provides clinically proven supplements for women's health and PCOS care.
|
|
| Locked | Locked | Locked |
Internet first brand of female intimate hygiene pharmaceuticals product
|
Detailed competitors of Gynoveda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gynoveda
Complete news archive for Gynoveda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gynoveda
Gynoveda was founded in 2019.
Gynoveda is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Gynoveda is a funded company, having raised a total of $10.95M across 3 funding rounds to date.
As of Oct 09, 2025, the latest employee count at Gynoveda is 95.
Annual revenue of Gynoveda is $7.85M as on Mar 31, 2024.
Founded in 2019 and based in Mumbai, India, dietary supplements and Ayurvedic solutions are provided by the company for womens health concerns. Menstrual issues such as PCOS, infertility, irregular and painful periods, and menopause are addressed through Ayurveda integrated with technology and educational content. Operations focus on the healthcare sector, targeting related disorders in the Indian market.
Gynoveda offers Fertility Tablets, PCOS Tablets, Delayed Periods Tablets, Early Periods Tablets, and 5 more products and services.
Gynoveda has 10 investors. Key investors include Ex Libris Group, Wipro, India Alternatives, Alteria Capital, and Wipro Enterprises.
The valuation of Gynoveda is $31.1M as of Mar 2023.